EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas

EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas

BackgroundEnhancer of zeste homolog 2 (EZH2) is a transcriptional enzyme implicated in tumor development and is often correlated to poor patient outcomes in various malignancies. The study evaluated various methods for EZH2 expression in lip and ear squamous cell carcinomas (LSCC, ESCC) by matching...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristian-Viktor Valea, Maurice Klein, Christian Hallermann, Hans-Joachim Schulze, Jan-Dirk Raguse, Kai Wermker
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
EZH2
prognostic factor
biomarker
lymph node metastasis
tumor marker
SCC
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1438021/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items